Skip to main content
All lobbying filings

ABBOTT LABORATORIES

Lobbying for ABBOTT LABORATORIES

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$900,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • LYNN SHA New on this filing
    Previously held: Legislative Fellow, Office of Sen. Tom Carper Legislative Assistant, Office of Sen. Tom Carper Health Policy Director, Office of Sen. Tom Carper

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 7
  • Centers For Medicare and Medicaid Services (CMS)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Office of Management & Budget (OMB)
  • SENATE
  • State, Dept of (DOS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 4
  • S 1000
    Saving Access to Laboratory Services Act
  • HR 1835
    Saving Access to Laboratory Services Act
  • HR 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
  • S 2426
    Equitable Community Access to Pharmacist Services Act
 Lobbying activity 5
Medicare/Medicaid

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals regarding the implementation and modernization of the WIC Program.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Health Issues

S. 2426 Equitable Community Access to Pharmacist Services Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem